Clinical Trials on Refractory Melanoma in Germany
Total 425 results
-
Krankenhaus NordwestTerminatedChemo-refractory MelanomaGermany
-
Fachklinik Hornheide an der Universität MünsterUnknownAdvanced Metastastic Malignant Melanoma | Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue MetastasesGermany
-
AstraZenecaCompletedRefractory MelanomaUnited States, Spain, Canada, France, Italy, United Kingdom, Argentina, Australia, Germany
-
Hasumi International Research FoundationActive, not recruitingMelanoma, Uveal MetastaticGermany
-
Bristol-Myers SquibbCompleted
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
University Hospital TuebingenGerman Research FoundationCompleted
-
Charite University, Berlin, GermanyUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Charite University, Berlin, GermanyUnknown
-
University of RegensburgUnknown
-
University of RegensburgClinAssess GmbHUnknown
-
University Hospital TuebingenUnknownMalignant Melanoma Stage IVGermany
-
Fachklinik Hornheide an der Universität MünsterWestfälische Wilhelms-Universität Münster; Deutsche RentenversicherungCompletedQuality of Life | Work Ability | Malignant Melanoma of SkinGermany
-
Ruhr University of BochumCompleted
-
University Hospital ErlangenCompleted
-
Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum...Unknown
-
European Organisation for Research and Treatment...Terminated
-
University Hospital ErlangenCompleted
-
University Hospital ErlangenCompleted
-
University Hospital MuensterUnknown
-
Philogen S.p.A.Active, not recruiting
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
University Hospital FreiburgUniversitätsklinikum Köln; Essex Pharma GmbHUnknownMalignant MelanomaGermany
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Charite University, Berlin, GermanyUnknownUveal Melanoma | Exudative Retinal DetachmentGermany
-
Ruhr University of BochumCompletedCutaneous Malignant MelanomaGermany
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Prof. Dr. med. Max. E. ScheulenClinAssess GmbHUnknownUveal MelanomaGermany
-
Cytos Biotechnology AGCompleted
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterTerminated
-
Bristol-Myers SquibbActive, not recruiting
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
Ruhr University of BochumCompletedCutaneous Melanoma | NeviGermany
-
University Hospital TuebingenDermatologic Cooperative Oncology GroupCompleted
-
PfizerCompletedMelanoma | Unresectable Metatstatic Cutaneous MelanomaSwitzerland, Germany, France
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Universitätsmedizin MannheimCompletedImmuno-monitoringGermany
-
BioNTech SECompleted
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany